Befejeződött1. fázis
Randomized, non-comparative, open-label early phase Ib study with OBT076 or OBT076 followed by Balstilimab in patients with Adenoid Cystic Carninoma of the Head and Neck
Key facts
- Where
- Avignon, Bordeaux, Caen Cedex 5, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier Cedex 5, Nice Cedex 2, Pierre-Bénite, St Herblain, Strasbourg, Toulouse, Tours Cedex 9, Vandoeuvre Les Nancy_ Cedex és Villejuif, FranciaországSee the 16 sites
- Phase
- 1. fázis
Where in Franciaország
- Institut Sainte-CatherineAvignon, FranciaországNo longer taking part
- Centre hospitalier Universitaire de BordeauxBordeaux, FranciaországNo longer taking part
- Centre Francois BaclesseCaen Cedex 5, FranciaországNo longer taking part
- Centre Jean PerrinClermont-Ferrand, FranciaországNo longer taking part
- Centre Oscar LambretLille, FranciaországNo longer taking part
- Centre Leon BerardLyon, FranciaországNo longer taking part
- Assistance Publique Hôpitaux de MarseilleMarseille, FranciaországNo longer taking part
- Institut Regional Du Cancer De MontpellierMontpellier Cedex 5, FranciaországNo longer taking part
- Centre Antoine LacassagneNice Cedex 2, FranciaországNo longer taking part
- Centre Hospitalier Lyon-SudPierre-Bénite, FranciaországNo longer taking part
- Institut De Cancerologie De L OuestSt Herblain, FranciaországNo longer taking part
- Institut de Cancérologie Strasbourg EuropeStrasbourg, FranciaországNo longer taking part
- Institut Claudius RegaudToulouse, FranciaországNo longer taking part
- Centre Hospitalier Regional Universitaire De ToursTours Cedex 9, FranciaországNo longer taking part
- Institut de cancérologie de LorraineVandoeuvre Les Nancy_ Cedex, FranciaországNo longer taking part
- Institut Gustave RoussyVillejuif, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Groupe Oncologie Radiotherapie Tete Cou
- Trial code
- EU 2023-503270-20-00
- Record updated
- 2024. június 3.